Maliheh Davari: Exploring CRISPR Activation for Hemophilia at ISTH 2026
Maliheh Davari, Postdoctoral Fellow at Queen’s University, shared a post on LinkedIn:
“I am thrilled to announce that I had the opportunity to present my study, ‘Targeted CRISPRa-Mediated Enhancement of Inverted F8 Exon 1–22 Fragment Expression in Hemophilic Canine Endothelial Cells’, at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris.
It was a great privilege to share our work with researchers and clinicians from around the world and to engage in valuable scientific discussions.
I would like to express my sincere gratitude to my supervisor, Dr. David Lillicrap, for his invaluable mentorship, continuous guidance, and unwavering support throughout this project.
Presenting at ISTH has been an enriching experience, and I look forward to continuing this research and contributing to advances in the field of thrombosis and hemostasis.”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?
-
Sep 18, 2026, 15:37Abdul Mannan: Evaluating Longitudinal Platelet Trends Beyond Standard Reference Intervals
-
Sep 18, 2026, 15:30Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research